Non-Inferiority Trials, Please, US FDA Implores Rheumatoid Arthritis Sponsors

 
• By Bridget Silverman
  
Arthritic hands
The US FDA would like to see non-inferiority trial designs in rheumatoid arthritis drug development. • Source: Shutterstock

More from Clinical Trials

More from R&D